In our previous study, we proposed that direct administration of SOD3 protein, as well as MSC-delivered SOD3 can exert efficient therapeutic efficacy against allergic dermatitis, allergic airway inflammation, and psoriasis-like skin inflammation [14,15,16]. The gene discussed is SOD3; the disease is atopic eczema.